PTC299 Completed Phase 1 Trials for Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00508586PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer